[1]
D. Avci and A. Cetinkaya, “Are dipeptidyl peptidase-4 inhibitors effective and safe in long term when added to ongoing therapies of diabetics? a real-life study in tertiary referral center”, Int J Adv Med, vol. 6, no. 2, pp. 264–270, Mar. 2019.